Cargando…

The expression landscape of JAK1 and its potential as a biomarker for prognosis and immune infiltrates in NSCLC

BACKGROUND: Janus-activated kinase-1 (JAK1) plays a crucial role in many aspects of cell proliferation, differentiation, apoptosis and immune regulation. However, correlations of JAK1 with prognosis and immune infiltration in NSCLC have not been documented. METHODS: We analyzed the relationship betw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Kaikai, Wei, Yuqing, Lv, Tangfeng, Song, Yong, Jiang, Xiaogan, Lu, Zhiwei, Zhan, Ping, Wang, Xianghai, Fan, Meng, Lu, Weihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482691/ https://www.ncbi.nlm.nih.gov/pubmed/34587898 http://dx.doi.org/10.1186/s12859-021-04379-y

Ejemplares similares

Long intergenic non-coding RNA 00467 promotes lung adenocarcinoma proliferation, migration and invasion by binding with EZH2 and repressing HTRA3 expression
por: Wang, Xianghai, et al.
Publicado: (2019)

Comparison between closed pleural biopsy and medical thoracoscopy for the diagnosis of undiagnosed exudative pleural effusions: a systematic review and meta-analysis
por: Wei, Yuqing, et al.
Publicado: (2020)

Aberrant Expression of β-Catenin Correlates with Infiltrating Immune Cells and Prognosis in NSCLC
por: Zheng, Hongmei, et al.
Publicado: (2021)

Identification of immune cell infiltration landscape for predicting prognosis of colorectal cancer
por: Wu, Xueqian, et al.
Publicado: (2023)

JAK3 and TYK2 Serve as Prognostic Biomarkers and Are Associated with Immune Infiltration in Stomach Adenocarcinoma
por: Meng, Lingkai, et al.
Publicado: (2020)

Comprehensive analysis of the prognosis and immune infiltration landscape of RNA methylation-related subtypes in pancreatic cancer
por: Lu, Siyuan, et al.
Publicado: (2022)

Immune checkpoint inhibitors alone vs immune checkpoint inhibitors—combined chemotherapy for NSCLC patients with high PD-L1 expression: a network meta-analysis
por: Wang, Yimin, et al.
Publicado: (2022)

Decreased expression of JAK1 associated with immune infiltration and poor prognosis in lung adenocarcinoma
por: Cai, Jinlian, et al.
Publicado: (2020)

Elevated exosome-derived miRNAs predict osimertinib resistance in non-small cell lung cancer
por: Li, Xinying, et al.
Publicado: (2021)

The Landscape of Immunotherapy Resistance in NSCLC
por: Frisone, Daniele, et al.
Publicado: (2022)

Identification of the Immune Cell Infiltration Landscape in Hepatocellular Carcinoma to Predict Prognosis and Guide Immunotherapy
por: Yang, Shiyan, et al.
Publicado: (2021)

PIG3 promotes NSCLC cell mitotic progression and is associated with poor prognosis of NSCLC patients
por: Li, Ming, et al.
Publicado: (2017)

Identification of STAT5B as a biomarker associated with prognosis and immune infiltration in breast cancer
por: Li, Jiaying, et al.
Publicado: (2023)

MicroRNA‐based biomarkers for diagnosis of non‐small cell lung cancer (NSCLC)
por: Liao, Jipei, et al.
Publicado: (2020)

Erratum: The landscape of immunotherapy resistance in NSCLC
Publicado: (2023)

Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients
por: Li, Chuling, et al.
Publicado: (2019)

Identification of necroptosis-related genes for predicting prognosis and exploring immune infiltration landscape in colon adenocarcinoma
por: Wang, Ye, et al.
Publicado: (2022)

Exploring the Immune Infiltration Landscape and M2 Macrophage-Related Biomarkers of Proliferative Diabetic Retinopathy
por: Meng, Zhishang, et al.
Publicado: (2022)

Identification and quantification of immune infiltration landscape on therapy and prognosis in left- and right-sided colon cancer
por: Guo, Jun-Nan, et al.
Publicado: (2021)

Characterization of the Immune Infiltration Landscape and Identification of Prognostic Biomarkers for Esophageal Cancer
por: Chen, Yuanmei, et al.
Publicado: (2022)

TRIM59 as a novel molecular biomarker to predict the prognosis of patients with NSCLC
por: Lou, Ming, et al.
Publicado: (2020)

Pseudogene KRT17P3 drives cisplatin resistance of human NSCLC cells by modulating miR‐497‐5p/mTOR
por: Hou, Zhibo, et al.
Publicado: (2020)

TMUB1 expression is associated with the prognosis of colon cancer and immune cell infiltration
por: Lu, Yan, et al.
Publicado: (2023)

Modification of the Histone Landscape with JAK Inhibition in Myeloproliferative Neoplasms
por: Greenfield, Graeme, et al.
Publicado: (2020)

Over-Expression of LSD1 Promotes Proliferation, Migration and Invasion in Non-Small Cell Lung Cancer
por: Lv, Tangfeng, et al.
Publicado: (2012)

Effect of activating cancer-associated fibroblasts biomarker TNC on immune cell infiltration and prognosis in breast cancer
por: Huang, Ting, et al.
Publicado: (2023)

CTHRC1 is a prognosis-related biomarker correlated with immune infiltrates in colon adenocarcinoma
por: Meng, Chuang, et al.
Publicado: (2022)

Revealing the Immune Infiltration Landscape and Identifying Diagnostic Biomarkers for Lumbar Disc Herniation
por: Wang, Linbang, et al.
Publicado: (2021)

Circulating noncoding RNAs: promising biomarkers in liquid biopsy for the diagnosis, prognosis, and therapy of NSCLC
por: Li, Yilin, et al.
Publicado: (2023)

Analysis of TRIM27 prognosis value and immune infiltrates in hepatocellular carcinoma
por: Wang, Haichuan, et al.
Publicado: (2022)

The current treatment landscape in the UK for stage III NSCLC
por: Evison, Matthew
Publicado: (2020)

FOXP family DNA methylation correlates with immune infiltration and prognostic value in NSCLC
por: Hu, Dong-Mei, et al.
Publicado: (2022)

Multi-omics analysis reveals PUS1 triggered malignancy and correlated with immune infiltrates in NSCLC
por: Tan, Yonghuang, et al.
Publicado: (2023)

Immune infiltration landscape on prognosis and therapeutic response and relevant epigenetic and transcriptomic mechanisms in lung adenocarcinoma
por: Zhang, Liangming, et al.
Publicado: (2022)

Implementation of programmed death-ligand 1 (PD-L1) expression as a prognostic biomarker for patients with lung cancer
por: Li, Huijuan, et al.
Publicado: (2022)

Pan-Cancer and Single-Cell Analysis Reveals CENPL as a Cancer Prognosis and Immune Infiltration-Related Biomarker
por: Feng, Ziyang, et al.
Publicado: (2022)

Lower SLC7A2 expression is associated with enhanced multidrug resistance, less immune infiltrates and worse prognosis of NSCLC
por: Jiang, Shanshan, et al.
Publicado: (2023)

Safety and efficacy of retreatment with immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysis
por: Cai, Zijing, et al.
Publicado: (2022)

Heparanase is a novel biomarker for immune infiltration and prognosis in breast cancer
por: Yang, Wen-Jing, et al.
Publicado: (2021)

OPN Polymorphism Is Related to the Chemotherapy Response and Prognosis in Advanced NSCLC
por: Hao, Yanzhang, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1rbvj870grjo8j17rdgkel39dh